Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

被引：0
|
作者：
Freiberg-Richter, Jens [1 ]
Hantzschel, Ingmar [1 ]
Jenke, Andreas [1 ]
Lorenz, Petra [1 ]
Ehninger, Gerhard [1 ]
Bornhaeuser, Martin [1 ]
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
756
引用
收藏
页码：227A / 227A
页数：1
相关论文
共 50 条
  • [21] Basiliximab in the treatment of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Ma, X
    Wu, DP
    Sun, AN
    BLOOD, 2005, 106 (11) : 426B - 426B
  • [22] Mycophenolate mofetil as acute graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation in a murine model.
    Huang, H
    Zheng, WY
    Lin, MF
    Fu, JY
    Zhang, RH
    BLOOD, 2001, 98 (11) : 325B - 325B
  • [23] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [24] Maximizing the Benefits of Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis
    Hamilton, Betty Ky
    Kalaycio, Matt
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1869 - 1870
  • [25] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Cheung, YK
    Van De Ven, C
    del Toro, G
    Garvin, J
    George, D
    Bradley, MB
    Wolownik, K
    Wischhover, C
    Levy, J
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 246 - 258
  • [26] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763
  • [27] Mycophenolate mofetil, cyclosporine and methotrexate as acute graft versus host disease prophylaxis after matched unrelated donor allogeneic bone marrow transplantation.
    Huang, H
    Lin, MF
    Lee, ZD
    Meng, HT
    Qian, WB
    Yan, LX
    Cai, Z
    BLOOD, 2000, 96 (11) : 361B - 361B
  • [28] Enteric-coated mycophenolate sodium in addition to standard graft-versus-host disease prophylaxis in allogeneic stem cell transplantation
    Sayer, HG
    Mügge, LO
    Klink, A
    Scholl, S
    Schmidt, V
    Schilling, K
    Höffken, K
    BONE MARROW TRANSPLANTATION, 2006, 37 : S95 - S96
  • [29] Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): Safety analysis
    Nash, RA
    Furlong, T
    Storb, R
    Anasetti, C
    Appelbaum, FR
    Deeg, HJ
    Doney, K
    Martin, P
    Witherspoon, R
    Sullivan, KM
    BLOOD, 1997, 90 (10) : 459 - 459
  • [30] Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation
    Mohty, Mohamad
    Malard, Florent
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 3993 - +
12345